Inspire Medical Systems Inc INSP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences
-
Inspire Medical Systems, Inc. Announces Second Quarter 2024 Financial Results and Updates 2024 Outlook
-
Inspire Medical Systems, Inc. Board Authorizes Share Repurchase Program
-
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
-
Inspire Medical Systems, Inc. Announces Preliminary Results for Second Quarter of 2024 and Updates 2024 Revenue Outlook
-
Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France
-
Inspire Medical Systems, Inc. Announces the Appointment of Melissa J. Mann as Chief People Officer
Trading Information
- Previous Close Price
- $208.42
- Day Range
- $206.41–213.32
- 52-Week Range
- $123.00–257.40
- Bid/Ask
- $206.05 / $208.18
- Market Cap
- $6.18 Bil
- Volume/Avg
- 328,188 / 658,885
Key Statistics
- Price/Earnings (Normalized)
- 1,150.56
- Price/Sales
- 8.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,011
- Website
- https://www.inspiresleep.com
Comparables
Valuation
|
Metric
|
INSP
|
TCMD
|
SIBN
|
|---|---|---|---|
Price/Earnings (Normalized) | 1,150.56 | 26.37 | — |
Price/Book Value | 9.67 | 1.71 | 3.47 |
Price/Sales | 8.67 | 1.23 | 3.73 |
Price/Cash Flow | 58.08 | 14.55 | — |
Price/Earnings
INSP
TCMD
SIBN
Financial Strength
|
Metric
|
INSP
|
TCMD
|
SIBN
|
|---|---|---|---|
Quick Ratio | 7.91 | 3.77 | 7.99 |
Current Ratio | 9.25 | 4.44 | 9.17 |
Interest Coverage | — | — | −12.97 |
Quick Ratio
INSP
TCMD
SIBN
Profitability
|
Metric
|
INSP
|
TCMD
|
SIBN
|
|---|---|---|---|
Return on Assets (Normalized) | 11.56% | 11.66% | −6.03% |
Return on Equity (Normalized) | 13.47% | 17.56% | −8.10% |
Return on Invested Capital (Normalized) | 10.19% | 13.44% | −8.97% |
Return on Assets
INSP
TCMD
SIBN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Pcdrrzqb | Nbwqptj | $196.1 Bil | |||
| Stryker Corp
SYK
| Qsqqbxbgp | Ynhz | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Flslzms | Dxgczr | $122.3 Bil | |||
| Medtronic PLC
MDT
| Ykcpsscp | Dsbvs | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Gxcrgfcbk | Vhwfjpk | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Lnjgg | Pgvb | $29.3 Bil | |||
| DexCom Inc
DXCM
| Bkkvpdtfc | Ydqp | $27.1 Bil | |||
| Steris PLC
STE
| Yjjprrgdk | Tcbhl | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Gvhkdyhfrq | Pgpcm | $21.9 Bil | |||
| Insulet Corp
PODD
| Ngmhrpczx | Sskcs | $16.5 Bil |
United States